Sign Up for Our E-Newsletter

News: FDA Approves New CRC Drug for Phase I Clinical Trial

Posted on July 31, 2014

Research 1_small

Exciting news in the colon cancer world! Last week, the experimental drug MGD007 was cleared by the FDA for Phase I clinical trials in colon cancer, scheduled to start later this year. MGD007 is different from other drugs currently available because it kills cancer cells in a different way. Specifically, it binds to a protein on immune system cells (or T-cells) and directs them to kill cells that express a protein found on 95% of primary and metastatic colon cancer cells. Read more

Undy Team Tuesday: Push Your Tush

Posted on July 29, 2014

UTT - Push Your Tush

“There were people dressed as super heroes, somber families remembering loved ones lost and enthusiastic survivors celebrating their monumental fight. Although I could pick out my teammates from the crowd by their neon shirts, I felt alone. The emotion of the event overwhelmed me from the moment I arrived. It was a steamy day in downtown Philadelphia and my group of family and friends were joining me at the Colon Cancer Alliance’s Undy Run/Walk. It was the first thing colon cancer related event that I had ever participated in, and it was somewhere I never thought I would be.”

Read more

Prevention News You Can Use

Posted on July 21, 2014

bluestar_small

Study: Racial Disparity in Colon Cancer

Dr. John M. Carethers, a researcher at the University of Michigan Medical School, has conducted a study that may lead to concrete conclusions as to why African Americans have lower colon cancer survival rates. The study included African American and Caucasian colon cancer patients with a goal of determining if the groups had a genetic marker called microsatellite instability (MSI). Patients with MSI tumors have higher survival rates, and it was found that 14% of Caucasians and 7% of African-Americans had MSI colon cancer. Read more

7/16: #80by2018 Stakeholder Meeting & Lobby Day

Posted on July 18, 2014

lobby day_small

We were thrilled to join Congressman Payne, Jr., Congressman Dent and Congressman Lance on Capitol Hill Wednesday for the 80 by 2018 Stakeholder Meeting and Lobby Day! This event was part of the ongoing national effort to make prevention a priority by achieving an 80% colon cancer screening rate by 2018. Since its launch, the 80 by 2018 movement has continued to gain momentum in the community with 100+ organizations now on board. To achieve this screening goal, we know we must remove obstacles that are preventing people from getting checked. That’s why we’re currently urging Congress to support HR 1070/S.2348, eliminating the colonoscopy loophole as a barrier to screening.   Read more

Board of Directors Spotlight: Kevin Lewis

Posted on July 14, 2014

PIP_666_2

Fifteen years ago, there wasn’t an organization dedicated to a comprehensive approach to addressing colon cancer.  As we celebrate our 15th anniversary, we’re proud to be leading the charge to knock colon cancer out of the top three cancer killers. Over the years we’ve seen increased screening rates, the approval of several new colon cancer fighting drugs and millions invested in lifesaving and supportive programs. In fact, in 2013 alone we invested $3.9 million in prevention, research and empowerment programs, providing hope to nearly one million patients, survivors, caregivers and advocates. Read more

css.php